Obesity an advantage in MHD patients
14th Nov 2006, 22:37 GMT
Despite significant improvements in dialysis treatments, currently over 20 percent of the 350,000 maintenance hemodialysis patients in the United States die each year. A study published in Hemodialysis International finds that this high mortality rate may be attributed to malnutrition.
Obesity an advantage in MHD patients related news:
- EU Warns of Obesity Crisis — The Christian Post RSS Feed
- Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug — Health News from Medical News Today
- Europe to draw up strategy against obesity (AFP) — Yahoo! News: Health News
- Neurogen's obesity drug in phase 1 trial — United Press International - Health Business
- Greeks Suffer Higher Rates of Obesity — www.heraldsun.com
- 'Diabetes wiping out indigenous peoples.' — Environmental Health News
- Obesity surgery just the first step for many — Reuters: Health
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Mayo Clinic research reveals 'broken heart syndrome' recurs in 1 of 10 patients — EurekAlert! - Medicine and Health
- Zydus Cadila files drug application to treat obesity — NewKerala Business India News
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away